Allarity Therapeutics Inc
Change company Symbol lookup
Select an option...
ALLR Allarity Therapeutics Inc
DARE Dare Bioscience Inc
REXR-C Rexford Industrial Realty Inc
AQNA Algonquin Power & Utilities Corp
NAOV Nanovibronix Inc
IOT Samsara Inc
GSIT GSI Technology Inc
GME GameStop Corp
CMBM Cambium Networks Corp
S SentinelOne Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Allarity Therapeutics, Inc. is a clinical-stage, precision medicine pharmaceutical company. It is advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its clinical program includes three anti-cancer assets in mid-stage clinical development and one anti-cancer asset in early-stage clinical development. Its programs and partnerships leverage its Drug Response Predictor technology to refine patient selection and improve clinical outcomes. It is focused on clinical development of three programs: dovitinib in combination with stenoparib for the second-line or later treatment of metastatic ovarian cancer; stenoparib as a monotherapy for ovarian cancer, and IXEMPRA as a monotherapy for metastatic breast cancer. Its dovitinib is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. Its IXEMPRA is a selective microtubule inhibitor, which has been shown to interfere with cancer cell division, to cell death.

Postmarket

Last Trade
Delayed
$0.2651
-0.0021 (-0.79%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.2672
Day's Change
0.011 (4.29%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
0.2799
Day's Low
0.2575
Volume
(Light)
Volume:
970,976

10-day average volume:
1,974,410
970,976
  • Prev Close
    0.2562
  • Today's Open
    0.2677
  • Day's Range
    0.2575-0.2799
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    1K
  • 52-Wk Range
    0.246 - 110.25
    LowHigh
  • (06/03/22 - 05/30/23)
    8.62%
  • 153.9%
  • Market Cap
    5.1M
  • Shares Outstanding
    19.1M
  • -63.23
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 0.01
  • (% of float 05/15/23)
    2.47

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.